Last reviewed · How we verify
99mTc-3PRGD2 injection — Competitive Intelligence Brief
phase 3
Small molecule
Live · refreshed every 30 min
Target snapshot
99mTc-3PRGD2 injection (99mTc-3PRGD2 injection) — RDO Pharm..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| 99mTc-3PRGD2 injection TARGET | 99mTc-3PRGD2 injection | RDO Pharm. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- 99mTc-3PRGD2 injection CI watch — RSS
- 99mTc-3PRGD2 injection CI watch — Atom
- 99mTc-3PRGD2 injection CI watch — JSON
- 99mTc-3PRGD2 injection alone — RSS
Cite this brief
Drug Landscape (2026). 99mTc-3PRGD2 injection — Competitive Intelligence Brief. https://druglandscape.com/ci/99mtc-3prgd2-injection. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab